These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15218636)

  • 21. [Infectious diseases in Poland in 2005].
    Zielińki A; Czarkowski MP
    Przegl Epidemiol; 2007; 61(2):177-87. PubMed ID: 17956029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elimination of hepatitis a infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis a immunization program.
    Belmaker I; Dukhan L; Yosef Y; Leventhal A; Dagan R
    Pediatr Infect Dis J; 2007 Jan; 26(1):36-40. PubMed ID: 17195703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A statistical model to estimate the impact of a hepatitis A vaccination programme.
    Oviedo M; Pilar Muñoz M; Domínguez A; Borras E; Carmona G
    Vaccine; 2008 Nov; 26(48):6157-64. PubMed ID: 18804511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
    Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
    J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis A and B virus immunization in HIV-infected persons.
    Laurence J
    AIDS Read; 2006 Jan; 16(1):15-7. PubMed ID: 16433468
    [No Abstract]   [Full Text] [Related]  

  • 27. Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain.
    Domínguez A; Oviedo M; Carmona G; Jansá JM; Borrás E; Salleras L; Plasència A
    J Viral Hepat; 2008 Oct; 15 Suppl 2():51-6. PubMed ID: 18837835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis A vaccines.
    Nothdurft HD
    Expert Rev Vaccines; 2008 Jul; 7(5):535-45. PubMed ID: 18564009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of the long-term protection after hepatitis A and B vaccination.
    Van Damme P; Van Herck K
    Travel Med Infect Dis; 2007 Mar; 5(2):79-84. PubMed ID: 17298912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up.
    Fisenka EG; Germanovich FA; Glinskaya IN; Lyabis OI; Rasuli AM
    J Viral Hepat; 2008 Oct; 15 Suppl 2():57-61. PubMed ID: 18837836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of Hepatitis A in Argentina after vaccination.
    Vacchino MN
    J Viral Hepat; 2008 Oct; 15 Suppl 2():47-50. PubMed ID: 18837834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
    Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
    J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A shot at hepatitis prevention.
    Voise N;
    J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S13-6. PubMed ID: 22086888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in epidemiology of viral hepatitis in Poland at the end of the 20th century.
    Kalinowski P
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):83-9. PubMed ID: 12898909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.
    Oldfield EC; Keeffe EB
    Rev Gastroenterol Disord; 2007; 7(1):1-21. PubMed ID: 17392626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretravel advice and hepatitis A immunization among Australian travelers.
    Zwar N; Streeton CL;
    J Travel Med; 2007; 14(1):31-6. PubMed ID: 17241251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and factors associated with self-reported vaccination rates among US adults at high risk of vaccine-preventable hepatitis.
    Chen H; Cantrell CR
    Curr Med Res Opin; 2006 Dec; 22(12):2489-96. PubMed ID: 17257463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing hepatitis A epidemiology and the need for vaccination in Korea.
    Kang JH; Lee KY; Kim CH; Sim D
    Asian Pac J Allergy Immunol; 2004 Dec; 22(4):237-42. PubMed ID: 15783137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis A and B vaccination and public health.
    Hollinger FB; Bell B; Levy-Bruhl D; Shouval D; Wiersma S; Van Damme P
    J Viral Hepat; 2007 Nov; 14 Suppl 1():1-5. PubMed ID: 17958635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.